Press Releases

View all news Print as PDF

Hologic Launches Breakthrough Business Intelligence Tool, Unifi™ Analytics, to Maximize Efficiency and Reduce Downtime in the Mammography Suite

February 11, 2019

MARLBOROUGH, Mass., February 11, 2019 -- Hologic, Inc. (Nasdaq: HOLX) announced today the U.S. launch of Unifi™ Analytics, a business intelligence tool that allows healthcare facilities to manage their mammography devices, monitor technologist performance, and prevent unanticipated downtime via predictive tube replacement technology. 

 Unifi Analytics tracks a facility’s installed base of mammography devices and provides statistical analysis of technology efficiency and technologist accuracy, allowing imaging centers to benchmark their performance against similar facilities, identify potential risks and challenges, and maximize device utilization. The web-based platform helps administrators make informed business decisions by providing actionable insights designed to optimize imaging center performance.

 Using advanced machine intelligence, Unifi Analytics has the ability to predict tube failures before they occur, allowing facilities to avoid costly downtime. Additionally, predictive procedure volume and quality metrics reports notify facilities if they move off target, giving them the opportunity to make immediate adjustments and potentially stay on top of Mammography Quality Standards Act (MQSA) compliance issues before they arise.

“As the leader in breast health, we are committed to identifying new and innovative ways to provide value to our customers, and the launch of Unifi Analytics represents a prime opportunity to build upon our reputation as the partner of choice for imaging centers across the country,” said Pete Valenti, Hologic’s Division President, Breast and Skeletal Health Solutions. “With reimbursement and payment landscapes shifting, and quality metrics and the patient experience becoming more important than ever, Unifi Analytics will serve a critical role for our partners. Our customers know they can rely on Hologic for cutting-edge, clinically proven breast health technology and unrivaled service, and we are confident they will feel the same about this new business intelligence offering.”

Data collected through Unifi Analytics is distributed through secure, encrypted channels and is de-identified in accordance with Health Insurance Portability and Accountability Act (HIPAA) privacy rules. No personal health information is collected or shared.

 Unifi Analytics is only compatible with Hologic mammography systems. For more information about Unifi Analytics, visit www.unificonnect.com.

 About Hologic, Inc.

Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

 Hologic, 3D Mammography, The Science of Sure and Unifi are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.

 Forward-Looking Statements

This news release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic products. There can be no assurance these products will achieve the benefits described herein or that such benefits will be replicated in any particular manner with respect to an individual patient, as the actual effect of the use of the products can only be determined on a case-by-case basis. In addition, there can be no assurance that these products will be commercially successful or achieve any expected level of sales. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such data or statements are based.

 This information is not intended as a product solicitation or promotion where such activities are prohibited. For specific information on what products are available for sale in a particular country, please contact a local Hologic sales representative or write to womenshealth@hologic.com.

Media Contact:

Jane Mazur

508.263.8764 (direct)

585.355.5978 (mobile)

jane.mazur@hologic.com

 

Investor Contact:

Michael Watts

858.410.8588

michael.watts@hologic.com

Categories: Press Releases
View all news

Quicklinks